-
A single injection has been approved for a fifth dose of DTaP and the fourth dose of inactivated polio (IPV) in children 4 to 6 years of age. The combination vaccine is marketed by GlaxoSmithKline as KINRIX.
-
Rosacea patients have increased incidence of small bowel bacterial overgrowth vs controls, and the eradication of this overgrowth leads to almost complete and long-lasting skin lesion regression.
-
-
For years, the debate has continued about returning the results of research to the study participants who made it possible. Would such a process be expensive and unwieldy? Could it cause more harm than good, when participants receive bad news?
-
When is the dual role of physician/investigator a conflict of interest? This is the question IRBs might consider in the aftermath of clinical trial participant Dan Markingson's suicide.
-
-
When the answer to the question of "Could there be incidental findings from this study?" is "Yes," experts agree that the protocol should include an incidental findings management plan.
-
Researchers using magnetic resonance imaging (MRI) in a cognitive psychology study note a suspicious mass in the brain of a supposedly healthy volunteer.
-
Sometimes IRB members will need to view a particular human subject research issue with more of an eye on what is the most ethical decision to make, as opposed to what is the best way to comply with rules and regulations.
-
A recent legal case involving a clinical trial participant who committed suicide raises a variety of questions for IRBs.